Cargando…

Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China

In 2015, only 49% of notified multi-drug resistant tuberculosis (MDR-TB) patients in China were estimated to have initiated treatment, compared with 90% of those worldwide. A case-control study was conducted to identify the reasons for non-enrollment in treatment among MDR-TB patients in Hunan provi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zuhui, Xiao, Tao, Li, Yanhong, Yang, Kunyun, Tang, Yi, Bai, Liqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5257000/
https://www.ncbi.nlm.nih.gov/pubmed/28114320
http://dx.doi.org/10.1371/journal.pone.0170718
_version_ 1782498792775352320
author Xu, Zuhui
Xiao, Tao
Li, Yanhong
Yang, Kunyun
Tang, Yi
Bai, Liqiong
author_facet Xu, Zuhui
Xiao, Tao
Li, Yanhong
Yang, Kunyun
Tang, Yi
Bai, Liqiong
author_sort Xu, Zuhui
collection PubMed
description In 2015, only 49% of notified multi-drug resistant tuberculosis (MDR-TB) patients in China were estimated to have initiated treatment, compared with 90% of those worldwide. A case-control study was conducted to identify the reasons for non-enrollment in treatment among MDR-TB patients in Hunan province, China. All detected MDR-TB patients registered in designated MDR-TB hospitals in Hunan province from 2011 to 2014 were included and followed until June 2015 to determine their treatment status. Approximately 33.8% (482/1425) of patients were not enrolled in standardized treatment. Factors associated with lower enrollment rate were: age greater than 60 years, living in rural area, unemployed or occupation unreported. Of those who were not enrolled in MDR-TB treatment, the primary reasons for non-enrollment included economic hardship (23.0%), out-migration for work (18.0%), concerns about work and studies (13.7%), and the belief that they were cured after undergoing drug-sensitive TB treatment (12.4%). Therefore, comprehensive strategies targeting priority populations, especially those enhancing treatment affordability and availability, need to be implemented to improve MDR-TB control.
format Online
Article
Text
id pubmed-5257000
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-52570002017-02-06 Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China Xu, Zuhui Xiao, Tao Li, Yanhong Yang, Kunyun Tang, Yi Bai, Liqiong PLoS One Research Article In 2015, only 49% of notified multi-drug resistant tuberculosis (MDR-TB) patients in China were estimated to have initiated treatment, compared with 90% of those worldwide. A case-control study was conducted to identify the reasons for non-enrollment in treatment among MDR-TB patients in Hunan province, China. All detected MDR-TB patients registered in designated MDR-TB hospitals in Hunan province from 2011 to 2014 were included and followed until June 2015 to determine their treatment status. Approximately 33.8% (482/1425) of patients were not enrolled in standardized treatment. Factors associated with lower enrollment rate were: age greater than 60 years, living in rural area, unemployed or occupation unreported. Of those who were not enrolled in MDR-TB treatment, the primary reasons for non-enrollment included economic hardship (23.0%), out-migration for work (18.0%), concerns about work and studies (13.7%), and the belief that they were cured after undergoing drug-sensitive TB treatment (12.4%). Therefore, comprehensive strategies targeting priority populations, especially those enhancing treatment affordability and availability, need to be implemented to improve MDR-TB control. Public Library of Science 2017-01-23 /pmc/articles/PMC5257000/ /pubmed/28114320 http://dx.doi.org/10.1371/journal.pone.0170718 Text en © 2017 Xu et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Xu, Zuhui
Xiao, Tao
Li, Yanhong
Yang, Kunyun
Tang, Yi
Bai, Liqiong
Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China
title Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China
title_full Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China
title_fullStr Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China
title_full_unstemmed Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China
title_short Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China
title_sort reasons for non-enrollment in treatment among multi-drug resistant tuberculosis patients in hunan province, china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5257000/
https://www.ncbi.nlm.nih.gov/pubmed/28114320
http://dx.doi.org/10.1371/journal.pone.0170718
work_keys_str_mv AT xuzuhui reasonsfornonenrollmentintreatmentamongmultidrugresistanttuberculosispatientsinhunanprovincechina
AT xiaotao reasonsfornonenrollmentintreatmentamongmultidrugresistanttuberculosispatientsinhunanprovincechina
AT liyanhong reasonsfornonenrollmentintreatmentamongmultidrugresistanttuberculosispatientsinhunanprovincechina
AT yangkunyun reasonsfornonenrollmentintreatmentamongmultidrugresistanttuberculosispatientsinhunanprovincechina
AT tangyi reasonsfornonenrollmentintreatmentamongmultidrugresistanttuberculosispatientsinhunanprovincechina
AT bailiqiong reasonsfornonenrollmentintreatmentamongmultidrugresistanttuberculosispatientsinhunanprovincechina